The North America left ventricular assist device market is expected to grow from US$ 540.59 million in 2022 to US$ 739.28 million by 2028. It is estimated to record a CAGR of 5.4% from 2022 to 2028.
In terms of application, the North America left ventricular assist device market is segmented into destination therapy, bridge to transplantation, bridge to candidacy, and bridge to recovery. The destination therapy segment held the largest market share in 2022.
The North America left ventricular assist device market, by country, is segmented into the US, Canada, and Mexico. The US dominated the market in 2022.
AO Kaspersky Lab; Avast Software s.r.o.; Cisco Systems, Inc.; ESET, spol. s r.o.; Fortinet, Inc.; McAfee, LLC; Microsoft Corporation; and Palo Alto Networks, Inc. are the leading companies operating in the North America left ventricular assist device market.
Increasing Geriatric Population Contributes to Market Growth of North America Left Ventricular Assist Device Market
The geriatric population is prone to conditions such as CVDs, orthopedic disorders, metabolic disorders, and neurological disorders. According to the US Census Bureau, ~13% of the population in the US was aged 65 and above in 2009, which is estimated to increase by 20% by the end of 2030. Per a study by Emory Healthcare, in the US, ~1.4 million people of age more than 65 have congestive heart failure, and more than 5% of people aged 60-69 have congestive heart failure. Additionally, the annual incidence of congestive heart failure is 10 per 1,000 among people aged 65 and above. Congestive heart failure is one of the most common diagnoses in patients of age 65 and above age, and the condition led to 875,000 hospitalizations in the US in 2021. Left ventricular assist devices are widely used in managing end-stage heart failure in the geriatric population. Hence, the elevating aging population base and the increasing prevalence of heart failure in this population fuel the North America left ventricular assist device market.North America Left Ventricular Assist Device Market Overview
The North America left ventricular assist device market is segmented into the US, Canada, and Mexico. The region accounted for the largest share of the global left ventricular assist device market in 2021 owing to the prevalence of cardiovascular diseases, especially in the geriatric population. A rise in the cases of heart failure and the inclusion of LVAD-associated costs under insurance are also contributing to the growth of the North America left ventricular assist devices market.North America Left Ventricular Assist Device Market Revenue and Forecast to 2028 (US$ Million) North America Left Ventricular Assist Device Market Segmentation
The North America left ventricular assist device market has been segmented on the basis of type of flow, design, and application, and country.- Based on the type of flow, the North America left ventricular assist device market is segmented into non-pulsatile and pulsatile flow. The non-pulsatile segment registered a larger market share in 2022.
In terms of application, the North America left ventricular assist device market is segmented into destination therapy, bridge to transplantation, bridge to candidacy, and bridge to recovery. The destination therapy segment held the largest market share in 2022.
The North America left ventricular assist device market, by country, is segmented into the US, Canada, and Mexico. The US dominated the market in 2022.
AO Kaspersky Lab; Avast Software s.r.o.; Cisco Systems, Inc.; ESET, spol. s r.o.; Fortinet, Inc.; McAfee, LLC; Microsoft Corporation; and Palo Alto Networks, Inc. are the leading companies operating in the North America left ventricular assist device market.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Left Ventricular Assist Device Market - By Type of Flow
1.3.2 North America Left Ventricular Assist Device Market - By Design
1.3.3 North America Left Ventricular Assist Device Market - By Application
1.3.4 North America Left Ventricular Assist Device Market - By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Left Ventricular Assist Device Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Experts Opinion
5. North America Left Ventricular Assist Device Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Target Diseases and Procedures
5.1.2 Uplifting Geriatric Population
5.2 Market Restraints
5.2.1 Rise in Product Recalls and Complications Associated with Left Ventricular Assist Devices
5.3 Future Trends
5.3.1 Increased Use of Artificial Intelligence and Machine Learning in LVAD
5.4 Impact Analysis
6. North America Left Ventricular Assist Device Market Analysis
6.1 North America Left Ventricular Assist Device Market Revenue Forecast & Analysis
7. North America Left Ventricular Assist Device Market Analysis - By Type of Flow
7.1 Overview
7.2 North America Left Ventricular Assist Device Market, By Type of Flow 2021 & 2028 (%)
7.3 Pulsatile Flow
7.3.1 Overview
7.3.2 Pulsatile Market Revenue and Forecast to 2028 (US$ Million)
7.4 Non-Pulsatile
7.4.1 Overview
7.4.2 Non-Pulsatile Market Revenue and Forecast to 2028 (US$ Million)
8. North America Left Ventricular Assist Device Market Analysis - by Design
8.1 Overview
8.2 North America Left Ventricular Assist Device Market, By Design 2021 & 2028 (%)
8.3 Implantable Ventricular Assist Devices
8.3.1 Overview
8.3.2 Implantable Ventricular Assist Devices Market Revenue and Forecast to 2028 (US$ Million)
8.4 Transcutaneous Ventricular Assist Devices
8.4.1 Overview
8.4.2 Transcutaneous Ventricular Assist Devices Market Revenue and Forecast to 2028 (US$ Million)
9. North America Left Ventricular Assist Device Market - By Application
9.1 Overview
9.2 North America Left Ventricular Assist Device Market, By Application 2021 & 2028 (%)
9.3 Bridge to Transplantation
9.3.1 Overview
9.3.2 Bridge to Transplantation Market Revenue and Forecast to 2028 (US$ Million)
9.4 Destination Therapy
9.4.1 Overview
9.4.2 Destination Therapy Market Revenue and Forecast to 2028 (US$ Million)
9.5 Bridge to Recovery
9.5.1 Overview
9.5.2 Bridge to Recovery Market Revenue and Forecast to 2028 (US$ Million)
9.6 Bridge to Candidacy
9.6.1 Overview
9.6.2 Bridge to Candidacy Market Revenue and Forecast to 2028 (US$ Million)
10. North America Left Ventricular Assist Device Market - Country Analysis
10.1 Overview
10.1.2 North America: Left Ventricular Assist Device Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 US: Left Ventricular Assist Device Market Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3 US: Left Ventricular Assist Device Market, by Type of Flow, 2019-2028 (US$ Million)
10.1.2.1.4 US: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
10.1.2.1.5 US: Left Ventricular Assist Device Market, by Application, 2019-2028 (US$ Million)
10.1.2.2 Canada: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Canada: Left Ventricular Assist Device Market Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3 Canada: Left Ventricular Assist Device Market, by Type of Flow, 2019-2028 (US$ Million)
10.1.2.2.4 Canada: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
10.1.2.2.5 Canada: Left Ventricular Assist Device Market, by Application, 2019-2028 (US$ Million)
10.1.2.3 Mexico: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 Mexico: Left Ventricular Assist Device Market Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 Mexico: Left Ventricular Assist Device Market, by Type of Flow, 2019-2028 (US$ Million)
10.1.2.3.4 Mexico: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
10.1.2.3.5 Mexico: Left Ventricular Assist Device Market, by Application, 2019-2028 (US$ Million)
11. Company Profiles
11.1 ABIOMED Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Abbott Laboratories
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Medtronic Plc
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 LivaNova Plc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Terumo Corp
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Berlin Heart GmbH
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 BiVACOR Inc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Evaheart Inc
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 BioVentrix Inc
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12. Appendix
12.1 About the Publisher
12.2 Glossary of Terms
List of Tables
Table 1. US: Left Ventricular Assist Device Market, by Type of Flow - Revenue and Forecast to 2028 (US$ Million)
Table 2. US: Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
Table 3. US: Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 4. Canada: Left Ventricular Assist Device Market, by Type of Flow - Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada: Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada: Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 7. Mexico: Left Ventricular Assist Device Market, by Type of Flow - Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico: Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico: Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 10. Glossary of Terms
List of Figures
Figure 1. North America Left Ventricular Assist Device Market Segmentation
Figure 2. North America Left Ventricular Assist Device Market, By Country
Figure 3. North America Left Ventricular Assist Device Market Overview
Figure 4. Implantable Ventricular Assist Device Held Largest Share for Design Segment in North America Left Ventricular Assist Device Market
Figure 5. The US is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Impact Analysis
Figure 9. North America Left Ventricular Assist Device Market - Revenue Forecast and Analysis - 2020- 2028
Figure 10. North America Left Ventricular Assist Device Market, by Type of Flow 2021 & 2028 (%)
Figure 11. Pulsatile Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Non-Pulsatile Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. North America Left Ventricular Assist Device Market, by Design 2021 & 2028 (%)
Figure 14. Implantable Ventricular Assist Devices Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Transcutaneous Ventricular Assist Devices Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. North America Left Ventricular Assist Device Market, by Application 2021 & 2028 (%)
Figure 17. Bridge to Transplantation Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Destination Therapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Bridge to Recovery Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Bridge to Candidacy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. North America: Left Ventricular Assist Device Market Revenue Overview, By Key Country - Revenue (2021) (US$ Million)
Figure 22. North America: Left Ventricular Assist Device Market, By Country, 2021 & 2028 (%)
Figure 23. US: Left Ventricular Assist Device Market Revenue and Forecast to 2028 (US$ Million)
Figure 24. Canada: Left Ventricular Assist Device Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. Mexico: Left Ventricular Assist Device Market Revenue and Forecast To 2028 (US$ Million)
Companies Mentioned
- ABIOMED Inc
- Abbott Laboratories
- Medtronic Plc
- LivaNova Plc
- Terumo Corp
- Berlin Heart GmbH
- BiVACOR Inc
- Evaheart Inc
- BioVentrix Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 104 |
| Published | January 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 540.59 Million |
| Forecasted Market Value ( USD | $ 739.28 Million |
| Compound Annual Growth Rate | 5.4% |
| Regions Covered | North America |
| No. of Companies Mentioned | 9 |
